These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 152375)

  • 21. Effect of immunization of bacterial adherence to urothelium.
    Uehling DT; Mizutani K; Balish E
    Invest Urol; 1978 Sep; 16(2):145-7. PubMed ID: 361628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inflammatory reaction and urinary leucocytes in ascending urinary-tract infections. An experimental study on rabbits infected with Proteus vulgaris X 19 and Escherichia coli 06.
    Gnarpe H; Olding L
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):208-14. PubMed ID: 4922733
    [No Abstract]   [Full Text] [Related]  

  • 23. Proposed dual antagonist approach for the prevention and treatment of urinary tract infections caused by uropathogenic Escherichia coli.
    Ribić R; Meštrović T; Neuberg M; Kozina G
    Med Hypotheses; 2019 Mar; 124():17-20. PubMed ID: 30798908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanical aid to control bladder infection and function using indwelling catheters.
    Barron J
    Dis Colon Rectum; 1967; 10(1):70-2. PubMed ID: 4289487
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.
    Aronson M; Medalia O; Schori L; Mirelman D; Sharon N; Ofek I
    J Infect Dis; 1979 Mar; 139(3):329-32. PubMed ID: 376757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder health: what goes in & what comes out.
    Ilardi D
    School Nurse News; 2010 Nov; 27(5):18-9. PubMed ID: 21067098
    [No Abstract]   [Full Text] [Related]  

  • 27. EXPERIMENTAL BLADDER NECK OBSTRUCTION. III. BACTERIOLOGY AND HISTOLOGY.
    ARBUCKLE LD; SPALDING BH; FOSTER EA; PAQUIN AJ
    Invest Urol; 1963 Nov; 1():208-15. PubMed ID: 14102151
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of ifosfamide-induced urotoxicity by disulfiram in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1989 Jan; 49(1):147-50. PubMed ID: 2724678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further characterization of bacterial adherence to urinary bladder mucosa: comparison with adherence to anion exchange resin.
    Ruggieri MR; Hanno PM; Levin RM
    J Urol; 1985 Nov; 134(5):1019-23. PubMed ID: 3932676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of induced urinary tract infection: an animal model to assess bladder immunization.
    Jensen J; Balish E; Mizutani K; Uehling DT
    J Urol; 1982 Jun; 127(6):1220-2. PubMed ID: 7045407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surface mucin in primary antibacterial defense of bladder.
    Parsons CL; Greenspan C; Moore SW; Mulholland SG
    Urology; 1977 Jan; 9(1):48-52. PubMed ID: 831354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous vesicostomy for temporary urinary diversion in infants.
    Lytton B; Weiss RM
    J Urol; 1971 Jun; 105(6):888-91. PubMed ID: 4933342
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
    Damiano R; Cicione A
    Int J Urol; 2012 Dec; 19(12):1112-3. PubMed ID: 23181521
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention and therapy of urinary tract infections after gynecologic and obstetric surgery].
    Bellmann O; Werner H; Weissbach L
    Gynakologe; 1982 Mar; 15(1):35-44. PubMed ID: 7042490
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How to prevent and treat bladder residue infections].
    Audic B
    Rev Prat; 1990 May; 40(14):1289-92. PubMed ID: 2359937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antibody effect on induced bladder infection.
    Uehling DT; Constant M
    Invest Urol; 1970 Jul; 8(1):62-5. PubMed ID: 4914799
    [No Abstract]   [Full Text] [Related]  

  • 40. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.